STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

Summary

Phase I/II trial to study the effectiveness of combining STI571 and chemotherapy in treating patients who have chronic myelogenous leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. STI571 may stop the growth of leukemia cells. Combining chemotherapy and STI571 may kill more cancer cells

Timeline

Start

2001-05

Primary completion

2003-04

Completion

—

Drugs

Indications